Key result
MitraClip reduces severe functional mitral regurgitation from grade 4+ to 1+ in case report.
Why the study?
Percutaneous mitral valve repair with MitraClip offers a treatment option for severe functional mitral regurgitation in patients at high surgical risk, but experience in Asia was limited.
Case Report (n=1)
May support feasibility in severe functional MR; leaves open efficacy and safety confirmation in randomized trials.
A 67-year-old Chinese woman with comorbidities of chronic obstructive lung disease, hypertension and prior coronary artery bypass surgery presented with severe functional mitral regurgitation (MR) and severely depressed left ventricular function. She was in New York Heart Association (NYHA) Class II-III. Due to high surgical risk, she was referred for percutaneous treatment with the MitraClip valve repair system. This procedure is typically performed via the femoral venous system and involves a transseptal puncture. A clip is delivered to grasp the regurgitant mitral valve leaflets and reduce MR. This was performed uneventfully in our patient, with reduction of MR from 4+ to 1+. She was discharged on post-procedure Day 2 and her NYHA class improved to Class I. This was the first successful MitraClip procedure performed in Asia and represents a valuable treatment option in patients with severe MR, especially those with functional MR or those at high surgical risk.
No takes yet. Share an insight, caveat, or question.
Yeo et al. (2013) conducted a case report in Severe functional mitral regurgitation (n=1). MitraClip valve repair system was evaluated on Reduction in mitral regurgitation severity. Percutaneous mitral valve repair with the MitraClip system successfully reduced severe functional mitral regurgitation from grade 4+ to 1+ and improved symptoms to NYHA Class I.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: